We found that Tip60 protein scoring is a biomarker to stratify breast cancer patients into specific cohorts, and low Tip60 expression (determined by microarray) is a significant risk factor indicating a higher chance of disease recurrence. This evidence concerns the gene KAT5 and breast cancer.